Literature DB >> 26267330

Re-conceptualizing ASD Within a Dimensional Framework: Positive, Negative, and Cognitive Feature Clusters.

Jennifer H Foss-Feig1, James C McPartland2, Alan Anticevic3, Julie Wolf4.   

Abstract

Introduction of the National Institute of Mental Health's Research Domain Criteria and revision of diagnostic classification for Autism Spectrum Disorder in the latest diagnostic manual call for a new way of conceptualizing heterogeneous ASD features. We propose a novel conceptualization of ASD, borrowing from the schizophrenia literature in clustering ASD features along positive, negative, and cognitive dimensions. We argue that this dimensional conceptualization can offer improved ability to classify, diagnose, and treat, to apply and predict response to treatment, and to explore underlying neural and genetic alterations that may contribute to particular feature clusters. We suggest the proposed conceptualization can advance the field in a manner that may prove clinically and biologically useful for understanding and addressing heterogeneity within ASD.

Entities:  

Keywords:  Autism spectrum disorder; Classification; Diagnosis; Heterogeneity; RDoC; Symptoms

Mesh:

Year:  2016        PMID: 26267330      PMCID: PMC5328688          DOI: 10.1007/s10803-015-2539-x

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  66 in total

Review 1.  The autistic spectrum: subgroups, boundaries, and treatment.

Authors:  Sophie H N Willemsen-Swinkels; Jan K Buitelaar
Journal:  Psychiatr Clin North Am       Date:  2002-12

Review 2.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

3.  Augmentation strategies in the treatment of schizophrenia.

Authors:  D C Goff; O Freudenreich; A E Evins
Journal:  CNS Spectr       Date:  2001-11       Impact factor: 3.790

Review 4.  Phenotype of schizophrenia: a review and formulation.

Authors:  C A Tamminga; H H Holcomb
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

Review 5.  Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

Authors:  P D Harvey; R S Keefe
Journal:  Am J Psychiatry       Date:  2001-02       Impact factor: 18.112

6.  A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia.

Authors:  D C Goff; L Leahy; I Berman; T Posever; L Herz; A C Leon; S A Johnson; G Lynch
Journal:  J Clin Psychopharmacol       Date:  2001-10       Impact factor: 3.153

7.  Autism during infancy: a retrospective video analysis of sensory-motor and social behaviors at 9-12 months of age.

Authors:  G T Baranek
Journal:  J Autism Dev Disord       Date:  1999-06

Review 8.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

9.  The heterogeneity of schizophrenia in disease states.

Authors:  Penny E Mohr; C Michael Cheng; Karl Claxton; Robert R Conley; Jacob J Feldman; William A Hargreaves; Anthony F Lehman; Leslie A Lenert; Ramy Mahmoud; Stephen R Marder; Peter J Neumann
Journal:  Schizophr Res       Date:  2004-11-01       Impact factor: 4.939

Review 10.  Model of autism: increased ratio of excitation/inhibition in key neural systems.

Authors:  J L R Rubenstein; M M Merzenich
Journal:  Genes Brain Behav       Date:  2003-10       Impact factor: 3.449

View more
  7 in total

1.  Mapping Research Domain Criteria using a transdiagnostic mini-RDoC assessment in mental disorders: a confirmatory factor analysis.

Authors:  Bernd R Förstner; Mira Tschorn; Nicolas Reinoso-Schiller; Lea Mascarell Maričić; Erik Röcher; Janos L Kalman; Sanna Stroth; Annalina V Mayer; Kristina Schwarz; Anna Kaiser; Andrea Pfennig; André Manook; Marcus Ising; Ingmar Heinig; Andre Pittig; Andreas Heinz; Klaus Mathiak; Thomas G Schulze; Frank Schneider; Inge Kamp-Becker; Andreas Meyer-Lindenberg; Frank Padberg; Tobias Banaschewski; Michael Bauer; Rainer Rupprecht; Hans-Ulrich Wittchen; Michael A Rapp
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-01       Impact factor: 5.270

2.  Elevated mirror neuron system activity in bipolar mania: Evidence from a transcranial magnetic stimulation study.

Authors:  Rakshathi Basavaraju; Urvakhsh M Mehta; Alvaro Pascual-Leone; Jagadisha Thirthalli
Journal:  Bipolar Disord       Date:  2018-12-12       Impact factor: 6.744

3.  Autism Spectrum Disorder and Schizophrenia Are Better Differentiated by Positive Symptoms Than Negative Symptoms.

Authors:  Dominic A Trevisan; Jennifer H Foss-Feig; Adam J Naples; Vinod Srihari; Alan Anticevic; James C McPartland
Journal:  Front Psychiatry       Date:  2020-06-11       Impact factor: 4.157

4.  Gene × Environment Interaction in Developmental Disorders: Where Do We Stand and What's Next?

Authors:  Gianluca Esposito; Atiqah Azhari; Jessica L Borelli
Journal:  Front Psychol       Date:  2018-10-26

Review 5.  Dopamine in Autism Spectrum Disorders-Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment.

Authors:  Vanja Mandic-Maravic; Roberto Grujicic; Luka Milutinovic; Ana Munjiza-Jovanovic; Milica Pejovic-Milovancevic
Journal:  Front Psychiatry       Date:  2022-02-03       Impact factor: 4.157

6.  Autism spectrum disorders: a meta-analysis of executive function.

Authors:  E A Demetriou; A Lampit; D S Quintana; S L Naismith; Y J C Song; J E Pye; I Hickie; A J Guastella
Journal:  Mol Psychiatry       Date:  2017-04-25       Impact factor: 15.992

7.  Automated recognition of spontaneous facial expression in individuals with autism spectrum disorder: parsing response variability.

Authors:  Abigail Bangerter; Meenakshi Chatterjee; Joseph Manfredonia; Nikolay V Manyakov; Seth Ness; Matthew A Boice; Andrew Skalkin; Matthew S Goodwin; Geraldine Dawson; Robert Hendren; Bennett Leventhal; Frederick Shic; Gahan Pandina
Journal:  Mol Autism       Date:  2020-05-11       Impact factor: 7.509

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.